McCarthy, P. L., Attwood, K. M., Liu, X., Chen, G. L., Minderman, H., Alousi, A., Bashey, A., Lowsky, R., Miklos, D. B., Hansen, J., Westervelt, P., Yanik, G., Waller, E. K., Howard, A., Blazar, B. R., Wallace, P. K., Reshef, R., Horowitz, M. M., Maziarz, R. T., … Mohammadpour, H. (2023). Galectin-3 predicts acute GvHD and overall mortality post reduced intensity allo-HCT: a BMT-CTN biorepository study. Bone Marrow Transplantation, 59(3), 334–343. https://doi.org/10.1038/s41409-023-02168-0
Subjects:
Graft vs Host Disease
(MeSH)
Grants:
U24CA076518
(NIH – National Cancer Institute)
P30CA016056
(NIH – National Cancer Institute)
R50CA211108
(NIH – National Cancer Institute)
R01HL056067
(NIH – National Heart, Lung, and Blood Institute)
P01HL158505
(NIH – National Heart, Lung, and Blood Institute)
R00HL155792
(NIH – National Heart, Lung, and Blood Institute)
U10HL069294
(NIH – National Heart, Lung, and Blood Institute)
UG1HL138645
(NIH – National Heart, Lung, and Blood Institute)
UG1HL109137
(NIH – National Heart, Lung, and Blood Institute)
K99HL155792
(NIH – National Heart, Lung, and Blood Institute)
U24HL138660
(NIH – National Heart, Lung, and Blood Institute)
R01AI145231
(NIH – National Institute of Allergy and Infectious Diseases)
R37AI034495
(NIH – National Institute of Allergy and Infectious Diseases)
Publication Type:
Article
Unique ID:
10.1038/s41409-023-02168-0
PMID:
Journal:
Publication Date:
Data Source:
PubMed
Source Link: